Alvimopan dihydrate
Cat.No:IA2140 Solarbio
CAS:170098-38-1
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
GPCR & G Protein >
Alvimopan dihydrateCAS:170098-38-1
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 170098-38-1 |
Name | Alvimopan dihydrate |
Molecular Formula | C25H36N2O6 |
Molecular Weight | 460.56 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD26142939 |
SMILES | OC1=CC=CC([C@@]2(C)[C@@H](C)CN(C[C@H](CC3=CC=CC=C3)C(NCC(O)=O)=O)CC2)=C1.O.O |
InChIKey | USPVLEIQIUNQGE-DBFLIVQGSA-N |
InChI | InChI=1S/C25H32N2O4.2H2O/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19;;/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30);2*1H2/t18-,20-,25+;;/m0../s1 |
PubChem CID | 5488547 |
Target Point | Opioid Receptor |
Passage | GPCR & G Protein;Neuronal Signaling |
Background | Alvimopan dihydrate is a potent, relatively nonselective opioid antagonist |
Biological Activity | Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan dihydrate can be used for the research of postoperative ileus[1-[3]. |
IC50 | 1.7nM(μ-opioid receptor)[1] |
In Vitro | Alvimopan inhibits the loperamide-stimulated [35S]GTPγS binding to membranes containing the cloned human μ-opioid receptor,with an IC50 of 1.7 nM[1]. |
In Vivo | Alvimopan(0.1-1.0 mg/kg; p.o.)partially antagonizes the slowing of small intestinal transit of 113Sn-labelled microspheres produced by morphine in rats.Alvimopan(3 mg/kg; p.o.)has no effect on the visceromotor behavioural responses(VMR)induced by noxious colorectal distension(CRD)in conscious rats[3]. |
Data Literature Source | [1] Goldina Ikezuagu Erowele. P T. 2008,33(10): 574,580-583. [2] DT Beattie. Clinical Medicine: Therapeutics. 2009,1: 199-213. |
Unit | Bottle |
Specification | 5mg 10mg 50mg |
是一种有效的、相对非选择性的opioid拮抗剂
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.